Post by
DeepValie on Jul 11, 2021 9:57am
game plan for q2/q3/q4
It looks like enthusiasm is building around cloudmd, and probably positionioning for Q3 of the invstors are under the way. No questions, shorts are around.
I think cloudmd has at least 15MM on hands, and no questions that exactly know what they are about to acquire next. Now, big question is when, and at what striking price?!
If Cloudmd wants to have positive EBITDA, I think they shouldn't do any significant acquisitions prior September 30(Q3 ends), or at least closing of the acquisitions should not happen before Sept30.
The way I see next six months trend: Q3, phenomenal results, positive EBITDA .. the stock goes over $3 easily. (I"m selling)
Acquisitions done at striking price(?)..., 15MM spent
Big financing around $3.. (I'm buying back)
Another set of acquisitions... but it shouldn't pull back under $2.7 (i'm buying more)
Comment by
madmax240kph on Jul 11, 2021 12:04pm
From last press release "After closing the acquisition of Oncidium, CloudMD will have approximately $55 million in cash, that is available to fund future growth."
Comment by
Tuatara on Jul 12, 2021 12:22pm
need to keep up: BMO has provided $62MM in LoC as announced at Oncidium Closing. DOC is more liquid than a swim pool and with Debt of $2MM or $7MM depending on whom you read